Skip to content

Clinical trials

Phase 2 Bone Diseases, Metabolic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 2 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20045
20051
20061
20073
20083
20092
20102
20117
20121
20134
20142
20153
20181
20192
20201
20212
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Unknown status5
Active, not recruiting3
Terminated3
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Northwestern University4
Odense University Hospital4
Massachusetts General Hospital3
Children's Hospital Medical Center, Cincinnati2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Thomas J. Schnitzer2
Alexandria University1
Azelon Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic52
Osteoporosis34
Bone Diseases8
Musculoskeletal Diseases6
Spinal Cord Injuries6
Osteoporosis, Postmenopausal5
Fractures, Bone4
Spinal Cord Diseases4
Central Nervous System Diseases3
HIV Infections3

Trials

Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.